4.5 Article

Synthesis and physicochemical characterization of Zn-Al layered double hydroxides (LDHs) as a delivery system for amphotericin B: In vitro and in silico antileishmanial study

期刊

HELIYON
卷 9, 期 4, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.heliyon.2023.e15308

关键词

Layered double hydroxides; Leishmaniasis; Amphotericin B; Drug delivery

向作者/读者索取更多资源

Leishmaniasis is a widespread neglected vector-borne protozoan disease that poses a major public health concern, with 12 million people affected worldwide and 60,000 deaths annually. Current chemotherapies for leishmaniasis have several drawbacks and side effects, prompting the development of new drug delivery systems. Layered double hydroxides (LDHs) have recently been considered due to their unique characteristics.
Leishmaniasis as a widespread neglected vector-borne protozoan disease is a major public health concern in endemic areas due to 12 million people affected worldwide and 60,000 deaths annually. Several problems and side effects in using current chemotherapies leads to progression of new drug delivery systems against leishmaniasis. For instance, layered double hydroxides (LDHs) so-called anionic clays due to their proper characteristics, have been considered recently. In the present study, LDH nanocarriers were prepared using co-precipitation method. Then, the intercalation reactions with amphotericin B were conducted via indirect ion exchange assay. Finally, after characterization of prepared LDHs, the anti-leishmanial effects of Amp-Zn/Al-LDH nanocomposites against Leishmania major were evaluated using an in vitro and in silico model. According to results, current study demonstrated that Zn/Al-NO3 LDH nanocarriers can be used as a new promising delivery system by intercalating amphotericin B into its interlayer space for leishmaniasis treatment by eliminating the L. major parasites by remarkable immunomodulatory, antioxidant and apoptotic effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据